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for 28 days, then the systolic, diastolic, mean pulmonary artery pressure (PASP,
PADP, mPAP) and right ventricle hypertrophy index (RVHI) were measured; the
pathological changes of small pulmonary arteries were observed, the thickness index
(TI) and area index (AI) of the small pulmonary arteries in three groups were eval-
uated with microscopy for morphological analysis; echocardiography measuring the
internal diameters of the pulmonary trunk assessed pulmonary hypertension in three
groups.
Results:①The PAP(PASP, PADP, mPAP) and RVHI in air embolism group were all
signiﬁcantly higher than these in control group, respectively (P<0.05), and these in
nicorandil treated group were signiﬁcantly lower than these in air embolism group,
respectively (20.473.91 mmHg VS 32.373.00 mmHg, 9.351.48 mmHg VS
13.491.62 mmHg, 13.741.86 mmHg VS 21.931.10 mmHg and 0.310.03 VS
0.470.13 P<0.05).②The thickness of wall increased and the cavity became narrow
in the small pulmonary arteries of air embolic group, and these were signiﬁcantly
ameliorated in the small pulmonary arteries of nicorandil treated group. The TI and AI
in the small pulmonary arteries of air embolic group were signiﬁcantly higher than
these in control group, respectively (P<0.05), and these in the small pulmonary
arteries of nicorandil treated group were signiﬁcantly lower than these in air embolic
group, respectively (0.380.12 VS 0.750.13, 0.600.16 VS 0.930.09 P<0.05).
③The internal diameters of the pulmonary trunk was higher in air embolic group
than that in control group(P<0.05); That was redused in nicorandil treated
group(0.780.06cm VS 0.930.14cm, P<0.05).
Conclusions: Nicorandil can signiﬁcantly attenuate the chronic air embolism-induced
pulmonary hypertension, improve pulmonary vascular remodeling of the small
pulmonary artery and right ventricular hypertrophy and reduse the internal diameters
of the pulmonary trunk.
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Objectives: High-density lipoprotein (HDL) cholesterol levels are a strong, inde-
pendent inverse predictor of cardiovascular disease. The present study aimed to
determine whether serum HDL cholesterol levels correlated with disease severity and
clinical outcomes in patients with idiopathic pulmonary arterial hypertension (IPAH).
The present study aimed to determine whether serum HDL cholesterol levels corre-
lated with disease severity and clinical outcomes in patients with idiopathic pulmonary
arterial hypertension (IPAH).
Methods: The serum HDL cholesterol levels were measured in 76 Chinese patients
with IPAH and 45 healthy controls, together with other clinical variables. Univariate
and multivariate Cox proportional hazards analysis was performed to assess the
prognostic value of HDL cholesterol and event-free survival. Event-free survival was
estimated using the Kaplan-Meier method.
Results: Serum HDL cholesterol levels were signiﬁcantly decreased in patients with
IPAH compared with controls (1.00.3 vs 1.50.3 mmol/L; P<0.001). The serum
HDL cholesterol levels decreased in proportion to the severity of World Health
Organization functional class. Compared to the high HDL cholesterol group, the low
HDL cholesterol group demonstrated a signiﬁcantly lower 6-minute walking distance,
cardiac index, mixed venous saturation, and arterial carbon dioxide pressure but
signiﬁcantly greater pulmonary vascular resistance and serum uric acid levels. The
serum HDL cholesterol levels correlated positively with the cardiac index (r¼0.42;
P¼0.002) and negatively with the pulmonary vascular resistance (r¼-0.25; P¼0.04).
Serum HDL cholesterol was independently related to event-free survival on multi-
variate Cox proportional hazards analysis. Kaplan-Meier survival curves according to
the median HDL cholesterol value showed that lower HDL cholesterol levels were
associated with lower event-free survival.
Conclusions: Serum HDL cholesterol levels might serve as an indicator of disease
severity and prognosis in patients with IPAH.
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Objectives: For the diagnostic awareness of acute pulmonary thromboembolism
(APTE) was increased in recent years, it became a relatively common cardiovascular
emergency. Because the pulmonary arterial bed is occluded by the thrombolus, usually
origenated from the deep vein of lower extrimities, an acute life-threatening right
ventricular failure might occur which could lead to severe shock and even death. It is a
difﬁcult diagnostic task for a clinician because of non-speciﬁc clinical presentation of
APTE. If early diagnosis were missed, the patients would die of acute right heart
failure, potentially fatal early recurrences or chronic right failure due to chronic
thromboembolic pulmonary hypertension. The clinical evaluation is important to
classify patients into probability categories corresponding to an increasing prevalence
of APTE.A prediction rule makes it possible to discriminate suspected APTE patientsJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cfor clinicians, that has become a key step in all diagnostic algorithms for APTE. The
most frequently used clinical prediction rule is Wells score that is based on early
clincal manifestations.But the reproducibility was variable due to one subjective item
in the rule (alternative diagnosis less likely than APTE). Thus the usefullness of Wells
score was limited. For the different medical system and policy of medical insurance
between western countries and China, it is much easier to collect ECG and echo-
cardiography information for Chinese physicians. In this study, the diagnositic pro-
bablity of suspected APTE based on the objective clinical tests was researched.
Methods: 425 consecutive cases of suspected APTE were enrolled, which included
161 conﬁrmed cases and 264 excluded cases according to the result of CT pulmonary
angiography. The items in Wells score including risk factors, symptoms and signs, and
two objective variables: electrocardiography (ECG) and echocardiography were
studied by Logistic multiple regression analysis.
Results: The odd ratio and 95% CI of the parameters above were: history of APTE or
deep venous thrombosis (DVT) 3.22 (1.13-5.20); Recent surgery or immobilization
2.66 (1.28-4.12); cancer1.34 (0.58-2.50); hemoptysis2.85 (1.14-4.97); heart rate >100
beats/min 1.02(0.93-1.40); clinical signs of DVT 2.28 (1.24-3.01); abnormal ECG
including negative T wave of lead V1-V4 or SIQIIITIII 2.21 (1.55-3.81); abnormal
echocardiography including dilation of right ventricle or increased estimated systolic
pulmonary arterial pressure 1.95 (1.30-3.18), P<0.05 respectively.
Conclusions: The abnormal ECG and echocardiography were risk factors for the
diagnosis of APTE, could be objective evidence for item ‘alternative diagnosis less
likely than APTE’ in Wells score for APTE. It might make Wells score operatable and
reproducible.
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Objectives: Studies have demonstrated that rennin angiotension system is involved in
the pathogenesis and development of pulmonary arterial hypertension (PAH). How-
ever, it is controversial whether angiotensin II type I receptor blockers attenuate PAH.
Here we examined the prevention effects of valsartan on experimental rodents of
PAH.
Methods:Male Sprague-Dawley rats with monocrotaline-induced PAH and male C57
mice with hypoxia-induced PAH were administered oral valsartan for 3 weeks.
Heamodynamic and anatomic data were determined in rats and mice. Histopathology,
immunohistochemistry, assessments of cell proliferation and stabilization of extra-
cellular matrix were performed in lung tissue of rats.
Results: In comparison with control rodents (rats and mice), valsartan markedly
improved the survival and decreased the RV systolic pressure and RV hypertrophy
index. Masson’s trichrome staining and immunohistochemical analyses revealed that
valsartan suppressed cell proliferation, attenuating the pulmonary vascular remodel-
ing. Further, western blot showed that valsartan inhibited the enhanced p38, JNK1/2
and ERK1/2 phosporylation in PAH rats. Similarly, active matrix metalloproteinase-2
(MMP-2) and MMP-9 were signiﬁcantly attenuated by valsartan. Furthermore, val-
sartan signiﬁcantly reduced the increase of TGF-b1 in rat lung tissue.
Conclusions: These results suggest that valsartan attenuates the progression of
PAH via inhibition of cell proliferation and MMPs expression and activity in
experimental rodents. Thus, valsartan might be a valuable prevention therapeutic
approach for PAH.
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Objectives: The American Collage of Chest Physicians indicated that infection is a
risk factor for VTE. And Inegrin aIIbb3, a kind of platelet membrane glycoprotein, is
the key factor affecting platelet activation. The aim of this study was to investigate the
gene expression correlation of cytokines and platelet activation-related mRNAs in
peripheral blood mononuclear cells between patients with symptomatic PE.
Methods: Twenty cases of PE patients and twenty sex and age matched controls were
recruited into the study. Human cDNA microarray analysis, random variance model
corrected T test and multiple linear regression analysis were used to analyze the
statistical data.
Results: (1) Fourteen platelet membrane glycoprotein mRNAs were detected. In PE
patients, 7 of them includingITGA2B and ITGB3 were up-regulated signiﬁcantly in
the PE group (P<0.01). 2). One hundred and twelve mRNAs of chemokines, in-
terleukins, colony-stimulating factors, interferons and tumor necrosis factors wereardiovascular-Disciplinary Research C217
detected. Compared with the controls, the differential expressions of 47 mRNAs had
statistical signiﬁcance (P<0.05). 3) In PE patients, multiple linear regression analysis
indicated that the expressions of CXCL3mRNAshad low positive correlations with
ITGA2B (R2¼0.247) and ITGB3 (R2¼0.247); The CXCL16 mRNA expression had a
low positive correlation with ITGA2B (R2¼0.201); The CXCL14 mRNA expression
had a low negative correlation with ITGB3 (R2¼0.212).
Conclusions: The results suggest that, in symptomatic PE patients, CXCL3, CXCL14
and CXCL16 mRNA were the cytokines which related to the activation of platelet.
CXCL3, CXCL14 and CXCL16 could be the triggering factors for the activation and
aggregation of platelets.
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Objectives: The genetic polymorphisms of coagulation factor V Leiden and
prothrombin G20210A are common risk factors of inherited thrombophilia in
Caucasians, but rare in Aisan. Factor V is an substrate of the activated protein C
anticoagulant system. While in Asian population, dysfunction of APC system
including protein C and protein S, and antithrombin is involved in thrombophilia.
The coagulation inhibitor protein deﬁciency consists of Protein C (PC), protein S
(PS) and antithrombin (AT). The previous studies showed that the prevalence of
coagulation inhibitor protein deﬁciency was 7% in European (Heijboer H, et al),
65% in Japanese (Kinoshito S, et al), 48% in Hong Kong Chinese (Liu HW, et al),
59% in Taiwan Chinese (Shen MC, et al) and 29% in mainland Chinese(Bai CM,
et al).It seems to be low estimated in mainland Chineses. As for aquired throm-
bophilia, antiphospholipid syndrome and hyperhomocysteinemia were the common
reasons.
Methods: From Jan 2011 to Dec 2013, consective139 patients( 71 male) of pulmo-
nary thromboembolism in the First Hospital of Jilin University were enrolled ly in this
study with exclusion of underlying diseases such as malignancy, myeloproliferative
disorder, nephrotic syndorme, liver disease and oral warfarin. The mean age was
5814 yrs. The diagnosis was conﬁrmed by CT pulmoanry agiography.Before oral
warfarin taken, the activity of blood protein C, protein S and antithrombin, as well as
serum anticardiolipin antibody (aCL) and homocysteinemia (Hcy) was assayed. The
normal range of the factors above is PC 70-140%, PS 76-135%, AT 80-120%, aCL
(IgG and IgM) 0-10U/L, Hcy 0-20mmol/L. The prevalance of kinds of thrombophilia
factor was calculated as the ratio of summary number of isolated and combined
containing the deﬁned factor. The combined deﬁciency included PC+PS, PC+AT,
PS+AT or PC+PS+AT. The prevalence of coagulation inhibitor protein deﬁciency
means the ratio of total number of patients with all kinds isolated or combined
coagulation inhibitor protein deﬁciency.
Results: The case number and prevalence of kinds of thrombophilia factor is PC 32
[23.0% (95%CI:16.0%-30.0%)], PS 65 [46.7% (38.5%-55.1%)], AT 14 [10.1%
(5.1%-15.1%)], aCL 14 [10.1% (5.1%-15.1%)], Hcy 30 [21.6% (14.7%-28.4%)],
combined deﬁciency 25 [18.0% (11.6%-24.4%)].The number of isolated deﬁciency
cases is PC 10, PS 42 and AT 5.The combined deﬁciency includes PC+PS 16, PC+AT
2, PS+AT 3, PC+PS+AT 4 respectively. The number of isolated aquired thrombo-
philia factor is aCL 3 and Hcy 12. There are also one combined aquired thrombophilia
(aCL+Hcy) case and combined congenital and aquired cases (PC+Hcy 3; PS+aCL 8;
PS+Hcy 7; AT+aCL 1; AT+Hcy 1; PC+PS+aCL 1; PC+PS+Hcy 5; PC+PS+AT+Hcy
1).The total number and prevalance ratio of patients with any kinds of congenital or
aquired thrombophilia factor is 98(70.5%).
Conclusions: The prevalence of coagulation inhibitor protein (PC, PS and AT)
deﬁciency in mainland Chinese is similar with that of other Aisan population. Besides
the congenital fators, aquired thrombophilia such antiphospholipid syndrome and
hyperhomocysteinemia should be considered in venous thromboembolism(VTE)
patients. The congenital along with aquired thrombophilia factors might explain nearly
2/3 VTE occurrence.
GW25-e0152
Effect of Th17 and Treg Axis Disorder on Outcomes of Pulmonary Arterial
Hypertension in Connective Tissue Diseases
Saren Gaowa1, Zhou Wenyong2, Jiang Hong1
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan,
2Department of Cardiothoracic Surgery, East Hospital, Tongji University, Shanghai
Objectives: This prospective cohort study is to verify the hypothesis that the balance
of Th17 and Treg cells frequencies in the peripheral circulation is disturbed in patients
with varying degrees of connective tissue diseases-associated pulmonary arterial
hypertension (CTD-aPAH), and to prove the inﬂuence of Th17/Treg imbalance on
prognosis.
Methods: We detected the frequencies of Th17 and Treg cells and related serum
cytokines secretion and expressions of key transcription factors in 117 patients with
connective tissue diseases (CTD), 53 patients with CTD-aPAH and 48 healthy
volunteers. Moreover, the median value according to levels of Th17/Treg ratios
in patients with CTD-aPAH was chosen as basis of group division for survival
analysis.C218 JACC Vol 64/16/Suppl C j October 1Results: CTD-aPAH patients revealed signiﬁcant increase in peripheral Th17 cells
number, Th17-related cytokines, and ROR gt mRNA levels. They also presented a
signiﬁcant decrease in Treg cells number, Treg- related cytokines, and Foxp3 mRNA
levels as compared with CTD patients and healthy controls. More importantly, the
Th17/Treg ratio was signiﬁcantly related to the severity and prognosis of CTD-aPAH.
Conclusions: This study indicated that the Th17/Treg axis disorder play a critical role
in CTD-aPAH. Furthermore, the dynamic balance between Th17 and Treg cells was
likely to inﬂuence prognosis of patients with CTD-aPAH.
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Objectives: To investigate the mRNA expression characterizations of FGA, FGB,
FGG, FIBCD1 and FCN, which were associated with ﬁbrinogen-related domain,
between patients with symptomatic pulmonary embolism and controls in their
peripheral blood mononuclear cells.
Methods: 20 cases of PE patients and twenty sex and age matched controls were
recruited into the study. Human cDNA microarray analysis was used to detect the
mRNA expression differences of FGA, FGB, FGG, FIBCD1 and FCN between two
groups, and random variance model corrected t test was used to analyze the statistical
data.
Results: Among the 7 mRNAs, the mRNA expressions of FGA, FGB and FGG were
down-regulated signiﬁcantly in the PE group, compared with the controls (P<0.05);
FIBCD1, FCN-1 and FCN-2 were up-regulated in the PE group (P<0.01); FCN-3 in
PE was up-regulated, but there was no signiﬁcant difference(P>0.05).
Conclusions: The mRNA expression of FGA, FGB and FGG in PE indicate that
body’s feedback mechanism plays a role to reduce further thrombosis; FIBCD1,
FCN-1 and FCN-2 in PE are up-regulated signiﬁcantly, suggest the expression levels
of related proteins which can activate the complement system are increased, and part
of innate immune molecules enhanced their function.
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Objectives: Whole human genome oligo microarray was employed to systematically
investigate the differential expression characteristics of associated mRNAs which
were found in the signal transduction pathway of the b2 integrin in peripheral blood
mononuclear cells (PBMCs) between patients with symptomatic pulmonary embolism
(PE) and controls.
Methods: 20 cases of PE patients and twenty sex- and age-matched controls were
recruited into the study. Human cDNA microarray analysis was used to detect the
differences of associated mRNAs expressions between two groups, and random
variance model corrected t test was used to analyze the statistical data.
Results: A total of 80 associated mRNAs were detected. The mRNA expres-
sions of chemokines, ligands, inside-out signal pathway associated proteins and
outside-in signal pathway associated proteins were up-regulated signiﬁcantly in
the PE group, compared with the controls. In 5 subunit-associated mRNAs,
the mRNA expressions of ITGAL, ITGAM, ITGAX and ITGB2, which encode
for the subunits of aL, aM, aX, b2, were up-regulated in the PE group, and the
differences except ITGB2 were statistically signiﬁcant (P<0.05). The mRNA
expression of ITGAD was down-regulated, but there was no signiﬁcant difference
(P>0.05). The expression of Fgr mRNA was signiﬁcantly down-regulated
(P<0.01).
Conclusions: Thus, in PE patients, bilateral signal transduction pathways of
b2 integrin in neutrophils and monocytes were activated, so innate immune
enhanced.
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Objectives: Renin-angiotensin system(RAS) is known to function in the development
of Pulmonary vascular remodeling. Losartan, a speciﬁc angiotensin II receptor
antagonist, is a well-known antihypertensive drug with a potential role in regulating
angiotensin - converting enzyme-2(ACE2). To determine the effect of losartan on
smoke-induced Pulmonary vascular remodeling and its possible mechanism.6–19, 2014 j GW-ICC Abstracts/Cardiovascular-Disciplinary Research
